Charles Leath, MD
Enriched profileDirector, Division of Gynecologic Oncology, Professor, Department of Obstetrics and Gynecology · University of Alabama at Birmingham
Charles Leath is Director, Division of Gynecologic Oncology, Professor, Department of Obstetrics and Gynecology at University of Alabama at Birmingham. OpenAlex indexes 433 publications with 8,987 citations (h-index 41); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.
Data verified 17 Oct 2026
Overview
Updated 18 Oct 2026
Charles Leath is Director, Division of Gynecologic Oncology, Professor, Department of Obstetrics and Gynecology at University of Alabama at Birmingham. The public record shows 433 publications with 8,987 citations (h-index 41), centered on Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, Cervical Cancer and HPV Research. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 19 companies, 3 NIH-funded awards (2016–2026).
- Most recent indexed publication: 2026 · PloS one
- Top research focus: Ovarian cancer diagnosis and treatment
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 19 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 123.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Industry payments
Updated 18 Oct 2026
19 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202514 payments$37,517openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year20253 payments
- Genmab U.S., Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
88.4%Opioid Agonist51.2%Oxycodone Hcl82%Morphine Sulfate Er18%Part D<11 patientsGabapentinoids37.2%Gabapentin58%Pregabalin42%Part D<11 patientsGenitourinary & hormones
11.6%Progestin11.6%Medroxyprogesterone Acetate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
3 NIH research awards on record, funded 2016–2026 per NIH RePORTER. The latest:
Congress activity
Updated 18 Oct 2026
41 congress contributions (2004–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Abstract 4114: Population-based patterns of human papillomavirus infections and cervical cancer incidence, driver mutations and overall survival
AACR Annual Meeting
AACR2026Co-author - Abstract 871: Surgical approach and five year survival in early stage cervical cancer: A national cancer database analysis.
AACR Annual Meeting
AACR2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
JCO precision oncology
Clinical Trial2026 - Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results.
Journal of clinical oncology
Clinical Trial2025 - Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005.
Journal of clinical oncology
Clinical Trial2024
Most-cited works
by citation count (OpenAlex)- 01Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian CancerArticle913 citations2019
- 02Pembrolizumab plus Chemotherapy in Advanced Endometrial CancerArticle761 citations2023
- 03Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyArticle715 citations2021
- 04
- 05NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022Article402 citations2022
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/charles-leath-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
join.targetedonc.com/authors/charles-a-trey-leath-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →join.targetedonc.com ↗ - Other
onclive.com/authors/charles-a-leath-iii-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - Other
onclive.com/authors/charles-a-trey-leath-iii-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
Mentions by others
where others cite or feature them- Other
nrgoncology.org/Scientific-Program/Disease-Specific-Scientific-Committees/Gynecologic-Cancer/Cervix-Vulva-Cancer-Subcommittee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nrgoncology.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
Editorial & leadership roles
journal and society appointments- Chair
NRG Oncology Cervix/Vulva Cancer Subcommittee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nrgoncology.org ↗
Awards & honors
honors on the public recordSecondary affiliations
appointments beyond the home institution- Medical Director
Uterus Transplant Program, University of Alabama at Birmingham
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗ - Member
Society of Gynecologic Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗ - Member
American Society of Clinical Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗ - Member
American College of Surgeons
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗ - Member
American Medical Association
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗ - Member
American Congress of Obstetricians & Gynecologists
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Bruce Korf, MD
University of Alabama at Birmingham
Michael Mugavero, MD
University of Alabama at Birmingham
Baha Sibai, MD
McGovern Medical School at UTHealth Houston
Robert Coleman, MD
Vaniam Group
Kathleen Moore, MD
University of Nebraska Medical Center
Bradley Monk, MD
Florida Cancer Specialists & Research Institute